Newsletter
Newsletter Support JNS

Former Israeli prime minister Barak appointed chair of medical marijuana company

In a statement, InterCure said Ehud Barak’s “stature” will be helpful for the company’s development.

Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.
Former Israeli Prime Minister Ehud Barak at the Saint Petersburg Economic Forum in 2015. Credit: Ministry of Digital Development, Communications and Mass Media of the Russian Federation.

Former Israeli Prime Minister Ehud Barak will chair the Israeli medical marijuana company InterCure, according to the firm, which made the announcement on Wednesday.

Barak served as defense minister and then prime minister in the early 2000s. He has remained in the public spotlight since leaving politics, usually criticizing current government policies.

InterCure said that Barak will head its global growth initiative. In a statement, the company said Barak’s “stature” will be helpful for the company’s development.

Barak will work 40 monthly hours for $10,000 per month. He will also be eligible for stock options, according to the company.

InterCure, publicly traded in Israel, is expected to change its name to Canndoc Pharma.

“We’re here to ensure that another 9/11 never happens again, and we’re not afraid to address that the reason 9/11 happened was because of radical Islamic terrorism,” Jayne Zirkle of Lawfare Project told JNS.
Danny Danon told JNS that it’s a “team effort” to help bridge the gap between governments saying that they will protect Jews and actually acting to do so.
Smotrich calls for Britain’s ambassador to be expelled; Ben-Gvir pushes for Israeli recognition of Argentine sovereignty over the Falkland Islands.
A similar deportation order was issued against an Israeli national for allegedly threatening the Frenchman and zoo staff on the island of Koh Samui.